Oral glucose-lowering agents vs insulin for gestational diabetes: a randomized clinical trial
Rademaker D, de Wit L, Duijnhoven RG, et al.
JAMA. Pub. online 6 Jan 2025.
Leggi
Breaking news
Metabolic interventions as adjunctive therapies to insulin in type 1 diabetes: current clinical landscape and perspectives
Podobnik J, Prentice KJ
Diabetes Obes Metab. Pub. online 6 Jan 2025.
Leggi
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): a population-based cohort study
Hopkins R, Young KG, Thomas NJ, et al.
Diabetes Obes Metab. Pub. online 6 Jan 2025.
Leggi
Long-term cognitive safety of achieving very low LDL cholesterol with evolocumab
Zimerman A, O’Donoghue ML, Ran X, et al.
NEJM Evid. 2025;4(1):EVIDoa2400112.
Leggi
A systematic review and meta-analysis of exercise-based intervention to prevent gestational diabetes in women with overweight or obesity
Santa Cruz TE, Sarasqueta C, Muruzábal JC, et al.
BMC Pregnancy Childbirth. 2025;25(1):5.
Leggi
Conceiving during the first postoperative year after bariatric surgery: a retrospective study of pregnancy outcomes
Kaukonen S, Pajula S, Gissler M, et al.
BMC Pregnancy Childbirth. 2024(1):862.
Leggi
Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials
Moiz A, Filion KB, Toutounchi H, et al.
Ann Intern Med. Pub. online 7 Jan 2025.
Leggi
Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin-treated type 2 diabetes – Two-year follow-up of the randomised controlled InterFast-2 trial
Azhar K, Ramirez-Obermayer A, Sourij C, et al.
Diabetes Obes Metab. Pub. online 2 Jan 2025.
Leggi